Similarly, we will confirm our signaling pathway analysis results in these new cell models using RNA-seq assays, and upon confirmation, perform additional immunohistochemistry (IHC) or immunofluorescence (IF) assays for protein targets in such signaling (e.g., PI3K for VEGF signaling [59]) using the corresponding ex vivo tumor tissues. Here, VEGFA is linked to neoplasm.